))
S3, E5 - Kent Hoskins; University of IL Cancer Center
Manage episode 390128636 series 2921209
Content provided by Equal Hope. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Equal Hope or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Mistrust in our healthcare system or failure to inform patients, what is the cause of lack of diversity in clinical trials in America? Dr. Patricia Robinson and John McIlwain explore this question with Dr. Kent Hoskins from the University of Illinois Cancer Center. Dr. Hoskins has been a key research partner and supporter of Equal Hope from our earliest days. As our medical and pharmaceutical industries grapple with how to create greater diversity in clinical trials to get to better testing and treatment results, we must first acknowledge and confront the inherent causes of our lack of diversity. Dr. Hoskins discusses not only trials for treatment protocols, but the importance of diversity in understanding tumor biomarkers.
35 episodes
Share
